October 20, 2021
1 min read
Save
ENVISAGE-TAVI AF
Issue: October 2021

Edoxaban (Savaysa, Daiichi Sankyo) or vitamin K antagonist in patients with atrial fibrillation after transcatheter aortic valve replacement.